Methoxyluteolin-FLAVONOIDS-NEUTRACETICALS INGREDIANTS

  • Methoxyluteolin-FLAVONOIDS-NEUTRACETICALS INGREDIANTS 1
  • Methoxyluteolin-FLAVONOIDS-NEUTRACETICALS INGREDIANTS 2
  • Methoxyluteolin-FLAVONOIDS-NEUTRACETICALS INGREDIANTS 3
Product Description

Description: Methoxyluteolin inhibits release of pro-inflammatory mediators from mast cells and decreases gene expression and release of TNF, VEGF and IL-8/CXCL8. The product also significantly inhibits IL-33 stimulated expression and release of CCL5 and CCL2. Methoxyluteolin pretreatment of LAD2 mast cells decreases gene expression of TNF, CXCL8 and VEGF in response to neurotensin or substance P via mTOR activation.



Read more Show less

DR VMR LABS PVT LTD

  • IN
  • 2023
    On CPHI since
  • 2
    Certificates
  • 1 - 24
    Employees
Company types
Academic/Research
Biopharmaceutical company
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
Distributor/Import Export
Drug delivery device Supplier/Manufacturer
Generics/Biosimilars Manufacturer
Innovation cluster
Manufacturer/Innovator
Pharmaceutical company
Start-up
Primary activities
API Producer
Biopharmaceutical
Chemical Development
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Generic APIs producer
Intermediates Manufacturer
Natural Extracts
Nutraceuticals
View company profile
Categories
more categories Show less
Specifications
  • CAS Registry Number
    855-97-0
  • Details
    Formula        :     C19H18O6 M.Wt              :      342.3 Appearance  :      Solid powder 
    Purity            :      >98% 
    PubChem ID :        631170
    Type of Compound:  Flavonoids
    Storage Desiccate at            Desiccate at -20°C
  • Selling Points
    Halal Ingredients; Natural Ingredients; Product Performance;
    Methoxyluteolin inhibits release of pro-inflammatory mediators
    Nutraceutical Ingredients
    Methoxyluteolin inhibits release of pro-inflammatory mediators from mast cells and decreases gene expression and release of TNF, VEGF and IL-8/CXCL8. The product also significantly inhibits IL-33 stimulated expression and release of CCL5 and CCL2. Methoxyluteolin pretreatment of LAD2 mast cells decreases gene expression of TNF, CXCL8 and VEGF in response to neurotensin or substance P via mTOR activation.
  • Model
    NEUTRACETICALS INGREDIANTS; FAVONOIDS; ALKOLOID
  • Supplied from
    India
  • Measured In
    kilogram
More specifications Fewer specifications
Sales Markets
Show more Show less

DR VMR LABS PVT LTD

  • IN
  • 2023
    On CPHI since
  • 2
    Certificates
  • 1 - 24
    Employees
Company types
Academic/Research
Biopharmaceutical company
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
Distributor/Import Export
Drug delivery device Supplier/Manufacturer
Generics/Biosimilars Manufacturer
Innovation cluster
Manufacturer/Innovator
Pharmaceutical company
Start-up
Primary activities
API Producer
Biopharmaceutical
Chemical Development
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Generic APIs producer
Intermediates Manufacturer
Natural Extracts
Nutraceuticals
View company profile

More Products from DR VMR LABS PVT LTD (2)

  • BIMATOPROST-MISOPROSTOL-PROSTAGLAND

    Product BIMATOPROST-MISOPROSTOL-PROSTAGLAND

    • Treat of glaucoma  • Bimatoprost is used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure (IOP) by increasing the outflow of aqueous fluid from the eyes. • For growth of lashes as cosmetic • It has...
  • HATU-HBTU-HOBT-PEPTIDE COUPLING REAGENTS-PEPTIDES

    Product HATU-HBTU-HOBT-PEPTIDE COUPLING REAGENTS-PEPTIDES

    HATU (Hexafluorophosphate Azabenzotriazole Tetramethyl Uronium) is a reagent used in peptide coupling chemistry to generate an active ester from a carboxylic acid. HATU is used along with Hünig's base (N,N-diisopropylethylamine, DIPEA), or triethylamin...

DR VMR LABS PVT LTD resources (1)

  • DR VMR LABS PVT LTD

    Technical Data DR VMR LABS PVT LTD

    Dr.VMR LABS PVT LTD is founded in 2019 as Contract Research Organization (CRO), Custom Research & Manufacturing Services (CRAMS), API intermediates and impurities to wide range of customers from USA, Canada, European and Asian countries
    Our ServicesMedicinal Chemistry/Synthetic Organic ChemistryLibrary Synthesis/ Parallel Synthetic ChemistryNucleoside/Sugar ChemistryAmino Acid/Peptide ChemistryAsymmetric/ Chiral ChemistryCustom Research & Manufacturing Services (CRAMS)API Intermediates and ImpuritiesStable Isotopic LabellingCOLLABORATION MODELSFull time equivalent (FTE).Fee for service (FFS) per library.Single price per compound.Research Development CapabilitiesSynthesis of Medicinal Chemistry 
    Analogus/ Library Compounds/ Scaffolds.
    Custom synthesis o...